The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more ...

Researchers have identified a new target to treat atherosclerosis, a condition where plaque clogs arteries and causes major cardiac issues, including stroke and heart attack.

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...